- 全部删除
- 您的购物车当前为空
Anticanceragent 273 (Compound 9q) 是源自苦参碱的强效抗癌药物。Anticanceragent 273 抑制癌细胞增殖,在 HeLa 细胞中的IC50为 4.48 μM。其通过调节 PI3K/AKT 的表达及激活转录因子4 (ATF4) 来发挥抗癌作用,诱发内质网应激并诱导细胞凋亡 (apoptosis)。Anticanceragent 273 有潜力应用于癌症研究,尤其是宫颈癌。
Anticanceragent 273 (Compound 9q) 是源自苦参碱的强效抗癌药物。Anticanceragent 273 抑制癌细胞增殖,在 HeLa 细胞中的IC50为 4.48 μM。其通过调节 PI3K/AKT 的表达及激活转录因子4 (ATF4) 来发挥抗癌作用,诱发内质网应激并诱导细胞凋亡 (apoptosis)。Anticanceragent 273 有潜力应用于癌症研究,尤其是宫颈癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
产品描述 | Anticanceragent 273 (Compound 9q) is an effective anticancer compound identified from matrine. It inhibits cancer cell proliferation, with an IC50 of 4.48 μM against HeLa cells. Anticanceragent 273 exerts its anticancer effects by modulating PI3K/AKT expression and activating activating transcription factor 4 (ATF4), which induces endoplasmic reticulum stress and triggers apoptosis. It holds potential for cancer research, including cervical cancer. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容